The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.
Implementation of the Interval Testing Procedure for functional data in different frameworks (i.e., one or two-population frameworks, functional linear models) by means of different basis expansions (i.e., B-spline, Fourier, and phase-amplitude Fourier). The current version of the package requires functional data evaluated on a uniform grid; it automatically projects each function on a chosen functional basis; it performs the entire family of multivariate tests; and, finally, it provides the matrix of the p-values of the previous tests and the vector of the corrected p-values. The functional basis, the coupled or uncoupled scenario, and the kind of test can be chosen by the user. The package provides also a plotting function creating a graphical output of the procedure: the p-value heat-map, the plot of the corrected p-values, and the plot of the functional data.
Version: | 2.1.1 |
Depends: | fda |
Published: | 2022-05-04 |
DOI: | 10.32614/CRAN.package.fdatest |
Author: | Alessia Pini, Simone Vantini |
Maintainer: | Alessia Pini <alessia.pini at polimi.it> |
License: | GPL-2 |
NeedsCompilation: | no |
Materials: | NEWS |
In views: | FunctionalData |
CRAN checks: | fdatest results |
Reference manual: | fdatest.pdf |
Package source: | fdatest_2.1.1.tar.gz |
Windows binaries: | r-devel: fdatest_2.1.1.zip, r-release: fdatest_2.1.1.zip, r-oldrel: fdatest_2.1.1.zip |
macOS binaries: | r-release (arm64): fdatest_2.1.1.tgz, r-oldrel (arm64): fdatest_2.1.1.tgz, r-release (x86_64): fdatest_2.1.1.tgz, r-oldrel (x86_64): fdatest_2.1.1.tgz |
Old sources: | fdatest archive |
Reverse imports: | robin |
Please use the canonical form https://CRAN.R-project.org/package=fdatest to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.